Interpretation of HER2 Immunohistochemistry: Agilent Dako HercepTest™

The page below is a sample from the LabCE course HER2 Testing in Breast Cancer. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about HER2 Testing in Breast Cancer (online CE course)
Interpretation of HER2 Immunohistochemistry: Agilent Dako HercepTest™

Agilent Dako gives scoring guidelines in the Food and Drug Administration (FDA) approved package insert as follows:
ScoreInterpretationDefinition
0NegativeNo staining is observed or membrane staining is in less than 10% of tumor cells.
1+NegativeMore than 10% of tumor cells show faint, barely perceptible membrane staining, but only part of the membrane is stained.
2+PositiveA weak to moderate complete membrane staining is observed in more than 10% of the tumor cells.
3+PositiveA strong complete membrane staining is observed in more than 10% of tumor cells.